Chemours Co. (CC) Reaches New 1-Year High at $14.84
Chemours Co. (NYSE:CC)’s share price hit a new 52-week high on Wednesday . The company traded as high as $14.84 and last traded at $14.74, with a volume of 2,687,753 shares trading hands. The stock had previously closed at $14.11.
A number of equities analysts have weighed in on CC shares. Vetr lowered shares of Chemours from a “hold” rating to a “sell” rating and set a $7.56 price target on the stock. in a report on Wednesday, June 8th. Jefferies Group reiterated a “hold” rating on shares of Chemours in a report on Wednesday, June 15th. Citigroup Inc. reiterated a “neutral” rating and issued a $9.00 price target (down previously from $10.50) on shares of Chemours in a report on Friday, July 15th. Argus upgraded shares of Chemours from a “hold” rating to a “buy” rating and set a $13.00 price target on the stock in a report on Wednesday, August 10th. They noted that the move was a valuation call. Finally, TheStreet upgraded shares of Chemours from a “sell” rating to a “hold” rating in a report on Tuesday, August 9th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating, three have issued a buy rating and one has issued a strong buy rating to the stock. The company currently has an average rating of “Hold” and an average target price of $11.94.
The stock’s market cap is $2.68 billion. The company has a 50-day moving average price of $12.47 and a 200 day moving average price of $9.49.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/22/chemours-co-cc-reaches-new-1-year-high-at-14-84.html
Chemours (NYSE:CC) last released its quarterly earnings results on Tuesday, August 9th. The company reported $0.27 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.17 by $0.10. Chemours had a negative net margin of 1.48% and a positive return on equity of 95.01%. The business had revenue of $1.38 billion for the quarter, compared to analyst estimates of $1.42 billion. During the same quarter in the previous year, the business earned ($0.10) earnings per share. The firm’s revenue was down 8.3% compared to the same quarter last year. Equities research analysts expect that Chemours Co. will post $0.92 earnings per share for the current fiscal year.
The company also recently declared a quarterly dividend, which was paid on Thursday, September 15th. Stockholders of record on Wednesday, August 17th were issued a dividend of $0.03 per share. The ex-dividend date of this dividend was Monday, August 15th. This represents a $0.12 dividend on an annualized basis and a dividend yield of 0.81%. Chemours’s dividend payout ratio is currently -26.09%.
Several large investors have recently added to or reduced their stakes in the stock. Mason Street Advisors LLC purchased a new stake in Chemours during the second quarter worth about $292,000. Schwab Charles Investment Management Inc. raised its position in Chemours by 115.2% in the second quarter. Schwab Charles Investment Management Inc. now owns 755,327 shares of the company’s stock valued at $6,224,000 after buying an additional 404,384 shares in the last quarter. Stifel Financial Corp bought a new position in Chemours during the second quarter valued at $322,000. Amalgamated Bank bought a new position in Chemours during the second quarter valued at $250,000. Finally, Legal & General Group Plc raised its position in Chemours by 71.7% in the second quarter. Legal & General Group Plc now owns 357,106 shares of the company’s stock valued at $2,940,000 after buying an additional 149,081 shares in the last quarter. Institutional investors and hedge funds own 76.63% of the company’s stock.
The Chemours Company is a provider of performance chemicals. The Company operates through three segments: Titanium Technologies, Fluoroproducts and Chemical Solutions. The Company’s Titanium Technologies segment manufactures titanium dioxide (TiO2), which is a pigment used to deliver whiteness, opacity, brightness and protection from sunlight in applications, such as architectural and industrial coatings, plastic packaging, polyvinyl chloride (PVC) window profiles, laminate papers, coated paper and coated paperboard used for packaging.
Receive News & Ratings for Chemours Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemours Co. and related companies with MarketBeat.com's FREE daily email newsletter.